LEXICON PHARMACEUTICALS INC (LXRX) Forecast, Price Target & Analyst Ratings

NASDAQ:LXRX • US5288723027

Current stock price

1.66 USD
-0.03 (-1.78%)
At close:
1.6985 USD
+0.04 (+2.32%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LEXICON PHARMACEUTICALS INC (LXRX).

Forecast Snapshot

Consensus Price Target

Price Target
$3.43
+ 106.46% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
9.567M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.43
Upside
+ 106.46%
From current price of $1.66 to mean target of $3.43, Based on 11 analyst forecasts
Low
$1.01
Median
$2.35
High
$6.30

Price Target Revisions

1 Month
15.07%
3 Months
16.67%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for LXRX. The average price target is 3.43 USD. This implies a price increase of 106.46% is expected in the next year compared to the current price of 1.66.
The average price target has been revised upward by 16.67% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LXRX Current Analyst RatingLXRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

LXRX Historical Analyst RatingsLXRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
LXRX was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LXRX.
In the previous month the buy percentage consensus was at a similar level.
LXRX was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-10CitigroupMaintains Buy -> Buy
2026-03-05HC Wainwright & Co.Maintains Buy -> Buy
2025-09-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-07CitigroupMaintains Buy -> Buy
2025-06-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-07NeedhamReiterate Hold -> Hold
2025-03-07Piper SandlerMaintains Overweight -> Overweight
2025-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-04Leerink PartnersDowngrade Outperform -> Market Perform
2025-03-03NeedhamReiterate Hold -> Hold
2025-03-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-29NeedhamReiterate Hold -> Hold
2025-01-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-23NeedhamReiterate Hold -> Hold
2024-11-25NeedhamReiterate Hold
2024-11-22NeedhamReiterate Hold
2024-11-13NeedhamReiterate Hold
2024-11-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-05HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-01NeedhamReiterate Hold
2024-11-01HC Wainwright & Co.Maintains Buy -> Buy
2024-10-30NeedhamReiterate Hold
2024-10-30HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
9.567M
Revenue Q2Q
658.08%
EPS Q2Q
49.87%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
66.01%
EPS (1 Month)
0.00%
EPS (3 Months)
47.08%

Next Earnings Summary

LXRX is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 9.57M USD.
The next earnings revenue estimate has been revised upward by 66.01% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LXRX revenue by date.LXRX revenue by date.
1.204M
1,104.00%		31.081M
2,481.48%		49.803M
60.24%		34.602M
-30.52%		20.026M
-42.12%		70.13M
250.19%		127.96M
82.46%		160.79M
25.66%		328.32M
104.19%		516.43M
57.29%		775.71M
50.21%
EBITDA
YoY % growth
LXRX ebitda by date.LXRX ebitda by date.
-171.196M
-70.51%		-196.583M
-14.83%		-48.29M
75.44%		-72.147M
-49.40%		-104.13M
-44.33%		-71.613M
31.23%		-91.29M
-27.48%		-52.02M
43.02%		N/AN/AN/A
EBIT
YoY % growth
LXRX ebit by date.LXRX ebit by date.
-171.75M
-70.39%		-197.117M
-14.77%		-48.911M
75.19%		-77.011M
-57.45%		-99.808M
-29.60%		-66.989M
32.88%		-40.666M
39.29%		22.872M
156.24%		225.45M
885.70%		406.81M
80.44%		657.67M
61.67%
Operating Margin
LXRX operating margin by date.LXRX operating margin by date.
-14,264.95%-634.20%-98.21%-222.56%-498.39%-95.52%-31.78%14.22%68.67%78.77%84.78%
EPS
YoY % growth
LXRX eps by date.LXRX eps by date.
-0.80
-31.15%		-0.64
20.00%		-0.14
78.13%		-0.18
-28.96%		-0.21
-16.38%		-0.11
47.86%		0.01
109.31%		0.06
500.00%		0.56
816.67%		1.02
81.82%		1.39
36.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.04
49.87%		-0.05
-618.16%		-0.05
-29.03%		-0.04
-12.20%		-0.06
-74.42%		-0.06
-18.11%		-0.05
1.19%		-0.05
-13.64%
Revenue
Q2Q % growth		9.567M
658.08%		4.544M
-84.26%		8.144M
-42.58%		10.511M
91.35%		918K
-90.40%		867K
-80.92%		918K
-88.73%		918K
-91.27%
EBITDA
Q2Q % growth		-16.424M
35.60%		-19.002M
-564.83%		-17.154M
-46.81%		-19.568M
-38.20%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-11.369M
55.73%		-18.395M
-592.38%		-21.742M
-78.40%		-20.737M
-40.30%		-31.191M
-174.35%		-29.91M
-62.60%		-26.94M
-23.91%		-23.682M
-14.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LXRX Yearly Revenue VS EstimatesLXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
LXRX Yearly EPS VS EstimatesLXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5 1 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.78%
EPS Next 5 Year
19.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.94%
Revenue Next 5 Year
27.00%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-4.40%
EBIT Next 5 Year
3.25%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LEXICON PHARMACEUTICALS INC / LXRX Forecast FAQ

Can you provide the average price target for LEXICON PHARMACEUTICALS INC stock?

11 analysts have analysed LXRX and the average price target is 3.43 USD. This implies a price increase of 106.46% is expected in the next year compared to the current price of 1.66.

When does LEXICON PHARMACEUTICALS INC (LXRX) report earnings?

LEXICON PHARMACEUTICALS INC (LXRX) will report earnings on 2026-04-30.

What are the consensus estimates for LXRX stock next earnings?

The consensus EPS estimate for the next earnings of LEXICON PHARMACEUTICALS INC (LXRX) is -0.04 USD and the consensus revenue estimate is 9.57M USD.

What is the expected long term growth rate for LXRX stock?

The expected long term growth rate for LEXICON PHARMACEUTICALS INC (LXRX) is 12.94%.